Aerosolized ribavirin: the most expensive drug for pneumonia

Dramatic, overnight cost increases of important orphan and generic medications have recently come under public and government scrutiny. We highlight the case of aerosolized ribavirin, an important antiviral agent in hematopoietic stem cell transplantation which, because of substantial price increase...

Full description

Saved in:
Bibliographic Details
Published in:Transplant infectious disease 2016-08, Vol.18 (4), p.634-636
Main Authors: Chemaly, R.F., Aitken, S.L., Wolfe, C.R., Jain, R., Boeckh, M.J.
Format: Article
Language:English
Subjects:
Administration, Inhalation
Adult
Aerosols
Antiviral Agents - administration & dosage
Antiviral Agents - economics
Antiviral Agents - therapeutic use
average wholesale price
Child
cost
Drug Costs
Drug Industry - ethics
Drugs, Generic - economics
Drugs, Generic - therapeutic use
Economics, Hospital - ethics
Health Policy - economics
hematologic malignancy
hematopoietic stem cell transplantation
Hematopoietic Stem Cell Transplantation - adverse effects
Hematopoietic Stem Cell Transplantation - economics
Humans
Infant
Orphan Drug Production - economics
pediatrics
Pneumonia, Viral - drug therapy
Price increases
respiratory syncytial virus
Respiratory Syncytial Virus Infections - drug therapy
Ribavirin - administration & dosage
Ribavirin - economics
Ribavirin - therapeutic use
Stem cells
Transplants & implants
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Dramatic, overnight cost increases of important orphan and generic medications have recently come under public and government scrutiny. We highlight the case of aerosolized ribavirin, an important antiviral agent in hematopoietic stem cell transplantation which, because of substantial price increases, may now cost more than the transplant procedure itself.
ISSN:1398-2273
1399-3062
DOI:10.1111/tid.12551